Patrick Kavanaugh focuses his practice on the representation of issuers and underwriters across a variety of public and private capital markets transactions, including initial public offerings and other equity offerings, debt offerings, tender offers and more. Patrick also regularly advises public companies on general corporate matters, including SEC reporting and corporate governance. 

Download full bio 


  • CinCor Pharma – $212 Million IPO 

  • SeatGeek to Combine With SPAC RedBall Acquisition Corp. 

  • Sprinklr – $293 Million IPO 

  • Immunocore – $297 Million IPO 


  • Vanderbilt University Law School
    JD, 2015

  • University of Florida
    BA, 2009

Admissions & Credentials

New York